Assembly Biosciences Inc
F:V7B1
Assembly Biosciences Inc
F:V7B1
Price:
3.2
EUR
8.11%
Market Cap:
€52.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Assembly Biosciences Inc
F:V7B1
|
US |
|
Rhoen Klinikum AG
F:RHKU
|
DE |
|
Inficon Holding AG
F:IFZ
|
CH |
|
H
|
Hanmi Financial Corp
F:HF7N
|
US |
|
G
|
Graham Holdings Co
SWB:WPOB
|
US |
|
D
|
Dunelm Group PLC
XBER:DFQ
|
UK |
|
S
|
Shell PLC
AEX:SHELL
|
UK |
|
Ardmore Shipping Corp
NYSE:ASC
|
BM |
|
E
|
Endesa SA
DUS:ENA
|
ES |
|
nCino Inc
F:6NCA
|
US |
|
Storebrand ASA
OSE:STB
|
NO |
|
RattanIndia Power Ltd
NSE:RTNPOWER
|
IN |
|
A
|
Aeris Resources Ltd
OTC:ARSRF
|
AU |
|
WELL Health Technologies Corp
F:W7V
|
CA |
|
L
|
Laramide Resources Ltd
F:L4R
|
CA |
|
Singapore Post Ltd
OTC:SPSTY
|
SG |
|
N
|
Novonix Ltd
NASDAQ:NVX
|
AU |
|
W
|
Western Alliance Bancorp
F:WEA
|
US |
|
Chargeurs SA
PAR:CRI
|
FR |
|
Lion Electric Co
NYSE:LEV
|
CA |
Wall St Price Targets
V7B1 Price Targets Summary
Assembly Biosciences Inc
Assembly Biosciences Inc
Wall Street analysts forecast V7B1 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for V7B1 is 5.74 EUR with a low forecast of 4.66 EUR and a high forecast of 7.51 EUR.
Lowest Forecast
Price Target
4.66
EUR
46% Upside
Average Forecast
Price Target
5.74
EUR
79% Upside
Highest Forecast
Price Target
7.51
EUR
135% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is V7B1's stock price target?
Price Target
5.74
EUR
5.74
EUR
According to Wall Street analysts, the average 1-year price target for V7B1 is 5.74 EUR with a low forecast of 4.66 EUR and a high forecast of 7.51 EUR.
What is the Revenue forecast for Assembly Biosciences Inc?
Projected CAGR
19%
19%
The compound annual growth rate for Revenue over the next 8 years is 19%.
